Rommelag specializes in Blow-Fill-Seal filling and contract manufacturing for liquids and semi-solid products, self-described as a unique partner for the pharmaceutical, chemical, food, and cosmetics industries.

Rommelag

KRAIBURG TPE is a global manufacturer of thermoplastic elastomers (TPE) that offers soft, elastic, and light TPE compounds for the automotive, consumer, industrial, and medical sectors.

KRAIBURG TPE

Krones AG, together with its subsidiaries, plans, develops, and manufactures machines and lines for the production, filling, and packaging technology in Germany and internationally. It operates in two segments, Machines and Lines for Product Filling and Decoration, and Machines and Lines for Beverage Production/Process Technology. The company provides process technology systems for use in beer, craft beer, juice, milk, soft drink, water, and spirit; Steinecker phoebus membrane filters; systems for ozonisation of water; bottle design; stretch blow molders; bottle washing machines; filling technology systems; inspection technology systems; labelers; conveyors; product treatment systems; packaging technology systems; palletizing technology systems; block technology systems; and recycling systems. It also offers solutions for intralogistics, material flow technology, or warehousing for the beverage and food sector; and IT solutions. It serves breweries; beverage producers; and companies from the food, chemical, pharmaceutical, and cosmetic industries. Krones AG was founded in 1951 and is headquartered in Neutraubling, Germany.

Krones AG

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Metric
Company Name	Rommelag	KRAIBURG TPE	Krones AG	Siemens Healthineers AG
Symbol			KRN	SHL
MSH ID	COM:ROMMELAG	COM:KRAIBURG-TPE	COM:KRONES	COM:SIEMENS-HEALTHINEERS
Market	PRIVATE	PRIVATE	STOCKS	STOCKS
Sector	Commercial & Professional Services	Capital Goods & Industrials	Industrials	Healthcare
Industry	Packaging and Contract Manufacturing	Manufacturing	Industrial - Machinery	Medical - Devices
Country	DE	DE	DE	DE
Stage
Employee Count			19.35K	71K
Website	rommelag.com	kraiburg-tpe.com	krones.com	siemens-healthineers.com
LinkedIn
Founders

Metric
Market Cap		4.16B	63.81B
Enterprise Value
Monthly Web Traffic	14.83K		1.01M
Web Traffic Growth	-0.10		-0.14
Valuation
Raised Capital			2.50M

Metric
Revenue	4.99B	23.62B
Revenue (LTM)
Revenue (NTM)
Gross Profit	4.99B	8.94B
EBITDA		4.46B
Operating Income	4.99B	3.03B
Net Income	237.23M	2.05B
EPS	7.51	1.84
Diluted EPS	7.51	1.84
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.63	0.38
Operating Profit Margin	0.31	0.13
EBITDA Margin		0.19
Net Profit Margin	0.05	0.08
Return on Equity	0.18	0.10
Return on Assets	0.05	0.04
Return on Capital Employed	0.68	0.08

COM:ROMMELAG

Rommelag

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	15.30	38.55
P/B Ratio	2.13	3.22
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.86	2.83
EV Multiple	16.68	16.20

Metric
Days Sales Outstanding	139.64	136.10
Days Payables Outstanding	104.19	57.55
Days Inventory Outstanding	127.79	125.45
Operating Cycle	274.93	232.75
Cash Conversion Cycle	139.69	179.79
Asset Turnover	1.08	0.48

Metric
Operating Cash Flow		2.61B
Free Cash Flow		1.87B
Cash Flow to Debt	8.37	3.53
Operating Cash Flow/Sales	0.08	0.11
Free Cash Flow Yield	0.01	0.02

Metric
Cash & Equivalents		2.83B
Accounts Receivable		-445.73M
Inventory		4.41B
Goodwill		18.66B
Debt to Capitalization	0.03	0.47
Debt to Assets	0.04	0.01
Current Ratio	1.35	1.05
Quick Ratio	1.01	0.89

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue				0.09
SG&A to Revenue				0.17